FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019918070> ?p ?o ?g. }

• W2019918070 endingPage "e12556" @default.
• W2019918070 startingPage "e12556" @default.
• W2019918070 abstract "Background There is growing interest in soluble biomarkers that could be used on the group level for screening purposes in small proof of principle studies during early drug development. We investigated early changes in serum levels of several candidate biomarkers involved in cartilage and bone metabolism following the initiation of adalimumab as a prototypic active treatment in psoriatic arthritis (PsA) compared to placebo. Materials and Methods Twenty-four PsA patients were randomized to receive either adalimumab 40 mg s.c. every other week or placebo for 4 weeks, followed by an open label extension phase. Serum samples were obtained at baseline and after 4 and 12 weeks of treatment and analyzed for levels of CPII and PINP (synthesis of type II and type I procollagen), melanoma inhibitory activity (MIA) (chondrocyte anabolism), matrix metalloproteinase (MMP)-3, C2C and cartilage oligomeric matrix protein (COMP) (type II collagen degradation), osteocalcin (OC) (bone formation), NTX-I and ICTP (both type I collagen degradation). Results After 4 weeks, there was a significant decrease in serum MMP-3 levels in adalimumab-treated patients (P<0.005), while no change was observed in the placebo group. A significant increase in serum MIA was noted after adalimumab therapy (P<0.005) but not after placebo treatment. After 12 weeks, there was a marked reduction in serum MMP-3 in both groups (P<0.005), whereas other markers did not show significant changes compared to baseline. Conclusion MMP-3 and MIA could serve as soluble biomarkers associated with inflammation as well as joint remodelling and destruction and may, together with clinical evaluation and in combination with other biomarkers, assist in distinguishing between effective and ineffective therapy in small, proof-of-principle studies of short duration in PsA. Trial Registration Current Controlled Trials ISRCTN23328456" @default.
• W2019918070 created "2016-06-24" @default.
• W2019918070 creator A5012564728 @default.
• W2019918070 creator A5021685324 @default.
• W2019918070 creator A5032494628 @default.
• W2019918070 creator A5045133119 @default.
• W2019918070 creator A5046625022 @default.
• W2019918070 creator A5063830294 @default.
• W2019918070 creator A5085468214 @default.
• W2019918070 date "2010-09-03" @default.
• W2019918070 modified "2023-10-11" @default.
• W2019918070 title "Soluble Biomarkers of Cartilage and Bone Metabolism in Early Proof of Concept Trials in Psoriatic Arthritis: Effects of Adalimumab Versus Placebo" @default.
• W2019918070 cites W1958332057 @default.
• W2019918070 cites W1970758157 @default.
• W2019918070 cites W1980168991 @default.
• W2019918070 cites W1993271032 @default.
• W2019918070 cites W1997106678 @default.
• W2019918070 cites W2005041059 @default.
• W2019918070 cites W2022941966 @default.
• W2019918070 cites W2025858544 @default.
• W2019918070 cites W2026496011 @default.
• W2019918070 cites W2030821405 @default.
• W2019918070 cites W2030868812 @default.
• W2019918070 cites W2076953985 @default.
• W2019918070 cites W2083180635 @default.
• W2019918070 cites W2084654167 @default.
• W2019918070 cites W2087075812 @default.
• W2019918070 cites W2093521383 @default.
• W2019918070 cites W2096898523 @default.
• W2019918070 cites W2100936707 @default.
• W2019918070 cites W2106670287 @default.
• W2019918070 cites W2107721723 @default.
• W2019918070 cites W2110177517 @default.
• W2019918070 cites W2119944271 @default.
• W2019918070 cites W2122980756 @default.
• W2019918070 cites W2123784732 @default.
• W2019918070 cites W2127692829 @default.
• W2019918070 cites W2136046755 @default.
• W2019918070 cites W2137833678 @default.
• W2019918070 cites W2142497985 @default.
• W2019918070 cites W2147696136 @default.
• W2019918070 cites W2148079442 @default.
• W2019918070 cites W2150250410 @default.
• W2019918070 cites W2168505126 @default.
• W2019918070 cites W4211046919 @default.
• W2019918070 doi "https://doi.org/10.1371/journal.pone.0012556" @default.
• W2019918070 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2937309" @default.
• W2019918070 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20844595" @default.
• W2019918070 hasPublicationYear "2010" @default.
• W2019918070 type Work @default.
• W2019918070 sameAs 2019918070 @default.
• W2019918070 citedByCount "38" @default.
• W2019918070 countsByYear W20199180702012 @default.
• W2019918070 countsByYear W20199180702013 @default.
• W2019918070 countsByYear W20199180702014 @default.
• W2019918070 countsByYear W20199180702015 @default.
• W2019918070 countsByYear W20199180702016 @default.
• W2019918070 countsByYear W20199180702017 @default.
• W2019918070 countsByYear W20199180702018 @default.
• W2019918070 countsByYear W20199180702019 @default.
• W2019918070 countsByYear W20199180702020 @default.
• W2019918070 countsByYear W20199180702021 @default.
• W2019918070 countsByYear W20199180702022 @default.
• W2019918070 countsByYear W20199180702023 @default.
• W2019918070 crossrefType "journal-article" @default.
• W2019918070 hasAuthorship W2019918070A5012564728 @default.
• W2019918070 hasAuthorship W2019918070A5021685324 @default.
• W2019918070 hasAuthorship W2019918070A5032494628 @default.
• W2019918070 hasAuthorship W2019918070A5045133119 @default.
• W2019918070 hasAuthorship W2019918070A5046625022 @default.
• W2019918070 hasAuthorship W2019918070A5063830294 @default.
• W2019918070 hasAuthorship W2019918070A5085468214 @default.
• W2019918070 hasBestOaLocation W20199180701 @default.
• W2019918070 hasConcept C1008401 @default.
• W2019918070 hasConcept C105702510 @default.
• W2019918070 hasConcept C126322002 @default.
• W2019918070 hasConcept C131075544 @default.
• W2019918070 hasConcept C134018914 @default.
• W2019918070 hasConcept C142724271 @default.
• W2019918070 hasConcept C160160445 @default.
• W2019918070 hasConcept C170033053 @default.
• W2019918070 hasConcept C181199279 @default.
• W2019918070 hasConcept C185592680 @default.
• W2019918070 hasConcept C204787440 @default.
• W2019918070 hasConcept C27081682 @default.
• W2019918070 hasConcept C2776164576 @default.
• W2019918070 hasConcept C2776260265 @default.
• W2019918070 hasConcept C2777077863 @default.
• W2019918070 hasConcept C2778232976 @default.
• W2019918070 hasConcept C2779134260 @default.
• W2019918070 hasConcept C2780132546 @default.
• W2019918070 hasConcept C2780550940 @default.
• W2019918070 hasConcept C55493867 @default.
• W2019918070 hasConcept C64348721 @default.
• W2019918070 hasConcept C71924100 @default.
• W2019918070 hasConcept C90924648 @default.
• W2019918070 hasConceptScore W2019918070C1008401 @default.
• W2019918070 hasConceptScore W2019918070C105702510 @default.

• next